Track the 네이처셀 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 네이처셀 has published 1 reports. Market capitalisation: €1,607.7bn. The latest transaction was reported on 20 March 2026 (Purchase). Among the most active insiders: 라정찬. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
네이처셀 是一家健康和制药领域的公司,在 XKRX 市场上市。它专注于细胞疗法和生物制药产品的开发。